Company profile
Nuwellis, Inc.
NASDAQ:NUWEBiotechnology: Electromedical & Electrotherapeutic Apparatus
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01474200 | — | terminated | 2012-01-01 | 2014-07-01 | Nuwellis, Inc. | Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment |
| NCT05318105 | — | terminated | 2022-06-28 | 2025-10-06 | Nuwellis, Inc. | Ultrafiltration Versus IV Diuretics in Worsening Heart Failure |
| NCT00124137 | — | completed | 2004-04-01 | — | Nuwellis, Inc. | Ultrafiltration Versus Intravenous (IV) Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure: (UNLOAD) |
FDA applications (0)
No records yet.